medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 2

<< Back Next >>

Ann Hepatol 2017; 16 (2)

Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation

Ip S, HussainiT, Daulat A, Nalufar P, Erb SR, Yoshida EM, Marquez V

Language: English
References: 13
Page: 230-235
PDF size: 132.67 Kb.


ABSTRACT

Background. Chronic renal failure (CRF) is a significant cause of morbidity and mortality in post-liver transplantation (LT) recipients. The risk factors associated with the development of renal dysfunction are not clearly elucidated. Objectives. To examine the risk factors in the development of CRF in these patients. Material and methods. Retrospective case-cohort of liver transplant patients without baseline kidney dysfunction who developed chronic renal failure during their follow-up. Results. Of 370 patients, 254 met the inclusion criteria. 30% (76) of these patients had CRF of which 57% (43) were male. Age, estimated glomerular filtration rate (eGFR) at discharge, and HCV infection were found to be risk factors for CRF post-LT. The odds ratio of developing CRF was 1.4 (0.6-3.3) in males with HCV, 1.6 (0.7-3.9) in females without HCV and 4.4 (1.5-13.2) among females with HCV when compared to men without HCV. Conclusions. In this cohort of LT receipients of a major Canadian city, age, eGFR, and HCV infection were risk factors for CRF. Female gender and HCV increased this odds by a factor of more than 4.


REFERENCES

  1. Bahirwani R, Reddy KR. Outcomes after liver transplantation: chronic kidney disease. Liver Transpl 2009: 15 Suppl. 2: S70-4. doi: 10.1002/lt.21900.

  2. Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Ardonfer J, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003:349:931-40. doi: 10.1056/NEJMoa021744.

  3. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl 2004:10:349-55. doi: 10.1002/lt.20092.

  4. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000: 133: 592-9.

  5. Campbell MS, Rai J, Kozin E, Bloom RD, Markmann JF, Olthoff KM, Saked A, et al. Effects of sirolimus vs. calcineurin inhibitors on renal dysfunction after orthotopic liver transplantation. Clin Transplant 2007: 21: 377-84. doi: 10.1111/ j.1399-0012.2006.00653.x.

  6. Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ. Calcineurin inhibitor minimization protocols in liver transplantation. Transpl Int 2009: 22: 49-60. doi: 10.1111/ j.1432-2277.2008.00796.x.

  7. Burra P, Senzolo M, Masier A, Prestete H, Jones R, Samuel D, Villamil F. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Dig Liver Dis 2009: 41: 350-6. doi: 10.1016/j.dld.2008.09.018.

  8. Ramachandran J, Juneja R, John L, Dutta AK, Chen JW, Woodman RJ, Wigg AJ. Chronic kidney disease following liver transplantation: a South Australian experience. Transplant Proc 2010: 42: 3644-6. doi: 10.1016/j.transproceed. 2010.06.022.

  9. O'Riordan A, Wong V, McCormick PA, Hegarty JE, Watson AJ. Chronic kidney disease post-liver transplantation. Nephrol Dial Transplant 2006: 21: 2630-6. doi: 10.1093/ndt/gfl247.

  10. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002: 39: S1-266.

  11. Weismuller TJ, Lerch C, Evangelidou E, Strassburg CP, Lehner F, Schrem H, Klempnauer J, et al. A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation. Transpl Int 2015: 28: 519-28. doi: 10.1111/ tri.12522.

  12. Ble M, Aguilera V, Rubin A, Garcia-Eliz M, Vinaixa C, Prieto M, Berenguer M. Improved renal function in liver transplant recipients treated for hepatitis C virus with a sustained virological response and mild chronic kidney disease. Liver Transpl 2014: 20: 25-34. doi: 10.1002/lt.23756.

  13. Faisal N, Renner, EL, Bilodeau M, Aljudaibi B, Hirsch G, Yoshida EM, Hussaini T, et al. Impact of Sofosbuvir-Based Regimens on Renal Function in Liver Transplant Recipients: Results of a Multicenter Study. Hepatology 2015: 62 (Suppl.): 312-313A (abstract). Correspondence and reprint request: Vladimir Marquez, MDCM, M.Sc. Division of Gastroenterology, Diamond Health Care Center 5153-2775 Laurel Street Vancouver, BC. Canada, V5Z 1M9 Fax: 604-875-5373. 13. Faisal N, Renner, EL, Bilodeau M, Aljudaibi B, Hirsch G, Yoshida EM, Hussaini T, et al. Impact of Sofosbuvir-Based Regimens on Renal Function in Liver Transplant Recipients: Results of a Multicenter Study. Hepatology 2015: 62 (Suppl.): 312-313A (abstract).




2020     |     www.medigraphic.com